Partnerships and Commercialization

IPM through unprecedented level of collaboration and innovation will prioritize commercial efforts with the highest potential to bring the value of personalized medicine in patient’s lives and make the greatest impact on healthcare. Precision medicine mediated through technological advances are often made in the private sector but require partnerships to adopt into clinical practice. Concurrently, health care innovations made at the bench and clinic often require industry partners to ensure long-term sustainability. The extensive scientific and leadership ability possessed by IPM leaders will help to effectively collaborate with academic and industry partners and strategically assess the commercial potential of efficient and advanced technology and help bring product to market faster.

Whether enabling new partnerships with industry or help to license intellectual property by finding partners, IPM serves as a communication hub to help match the right stakeholders with the right opportunity, whether computational, at the bench or in the clinic.  In this way, IPM seeks to serve patients, providers, and payers in the longest planning horizon possible, catalyzing change as efficiently as possible.